Literature DB >> 19451873

UK guidelines for the systemic treatment of renal cell carcinoma.

Paul Nathan1, John Wagstaff, Emilio Porfiri, Tom Powles, Tim Eisen.   

Abstract

There have been recent significant improvements in treatment options for patients with advanced renal cell carcinoma. This article presents UK consensus guidelines on the use of systemic therapies for this poor prognosis disease.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19451873     DOI： 10.12968/hmed.2009.70.5.42228

Source DB:  PubMed          Journal:  Br J Hosp Med (Lond)        ISSN： 1750-8460            Impact factor:   0.825


  2 in total

1.  The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.

Authors:  T Powles; I Kayani; C Blank; S Chowdhury; S Horenblas; J Peters; J Shamash; N Sarwar; K Boletti; A Sadev; T O'Brien; D Berney; L Beltran; J Haanen; A Bex
Journal:  Ann Oncol       Date:  2011-01-17       Impact factor: 32.976

2.  Treatment patterns and clinical outcomes in patients with renal cell carcinoma in the UK: insights from the RECCORD registry.

Authors:  J Wagstaff; R Jones; R Hawkins; E Porfiri; L Pickering; A Bahl; J Brown; S Buchan
Journal:  Ann Oncol       Date:  2015-10-21       Impact factor: 32.976
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.